Skip to content
ChickenStockChickenStock
Research0009K0
Aimed Bio logo

Aimed Bio (0009K0) stock

KOSDAQ · Biotechnology

KRW 16,500-9.89%(-1,810)

As of the Nov 16 regular-session close (Korea)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · Nov 13, 2026 · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

237.46x

P/B

5.83x

P/S

25.23x

Earnings

Revenue, operating profit and net income from periodic reports filed with DART, Korea’s regulatory filing system.

Quarters and year-to-date
PeriodRevenueOperating profitNet incomeRevenue YoY
Q2 2026Consolidated · Filed Aug 12, 2026KRW 20.2 billionKRW 8.5 billionKRW 10.9 billion—
Q1 2026Consolidated · Filed May 15, 2026KRW 8.5 billion-KRW 4 billion-KRW 2 billion—
Q4 2025Consolidated · Filed Mar 19, 2026KRW 38 billionKRW 25.5 billionKRW 34.9 billion—
9M 2025Consolidated · Filed Dec 10, 2025KRW 9.3 billion-KRW 4.8 billion-KRW 29.9 billion—
Fiscal years
PeriodRevenueOperating profitNet incomeRevenue YoY
FY2025Consolidated · Filed Mar 19, 2026KRW 47.3 billionKRW 20.8 billionKRW 5 billion—
  • Q2 2026 is computed as H1 2026 minus Q1 2026.
  • Q4 2025 is computed as FY2025 minus 9M 2025.
  • Year-to-date rows are cumulative from the start of the fiscal year.
Original filing (DART)

Short selling and securities lending

Short sales as a share of trading value, the reported short position and the securities lending balance.

Short-sale share
11.39%
Of trading value on Nov 13, 2026
Short-sale value
KRW 660 million
Previous 20-day average 7.20%
Net short position
145,854 shares
As of Nov 11, 2026 · reported with a two-trading-day lag
Lending balance
2,714,128 shares
As of Nov 13, 2026 · 4.17% of listed shares
Recent short-sale days
DateShareValue
Nov 13, 202611.39%KRW 660 million
Nov 12, 20266.03%KRW 150 million
Nov 11, 20263.46%KRW 160 million
Nov 10, 20267.61%KRW 280 million
Nov 9, 202611.51%KRW 370 million
Nov 6, 20266.67%KRW 270 million
Nov 5, 202610.42%KRW 500 million
Nov 4, 20266.91%KRW 360 million
Nov 3, 202611.87%KRW 360 million
Nov 2, 20262.02%KRW 50 million

The short-sale share is short-sale value divided by total trading value that day. The lending balance also includes stock lent for purposes other than short selling.

Aimed Bio (0009K0) stock information

KOSDAQ

Aimed Bio (0009K0) is listed on KOSDAQ. Its market capitalization is about KRW 1.2 trillion. On trailing-twelve-month earnings the P/E ratio is 237.46, and the P/B ratio is 5.83. Return on equity is 2.5%. These figures are computed in-house from official filings and are reference information only.

Aimed Bio — frequently asked questions

What is the P/E ratio of Aimed Bio (0009K0)?
On a trailing-twelve-month basis, 0009K0 trades at a P/E ratio of 237.46. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Aimed Bio?
0009K0 has a market capitalization of about KRW 1.2 trillion. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.